Inbunden, Engelska, 2016
Del 104 i serien Advances in Protein Chemistry and Structural Biology
Ion Channels as Therapeutic Targets, Part B
Av Rossen Donev
2659 kr
Beställningsvara. Skickas inom 11-20 vardagar. Fri frakt för medlemmar vid köp för minst 249 kr.
Beskrivning
This volume is the second part of the thematic on Ion Channels as Therapeutic Targets.
The popular Advances in Protein Chemistry and Structural Biology series, an essential resource for protein chemists, brings forth new information about protocols and analysis of proteins, with each thematically organized volume guest edited by leading experts in a broad range of protein-related topics.
- Provides cutting-edge developments in protein chemistry and structural biology
- Discusses the use of ion channels as therapeutic targets
- Chapters are written by authorities in their field
- Targeted to a wide audience of researchers, specialists, and students
Produktinformation
- Utgivningsdatum: 2016-03-30
- Mått: 152 x 229 x undefined mm
- Vikt: 620 g
- Format: Inbunden
- Språk: Engelska
- Serie: Advances in Protein Chemistry and Structural Biology
- Antal sidor: 466
- Förlag: Elsevier Science
- ISBN: 9780128048269
Utforska kategorier
Mer information
Rossen Donev received his PhD degree in 1999 from the Institute of Molecular Biology, Bulgarian Academy of Sciences. He did postdoctoral training at Imperial Cancer Research Fund, UK (renamed after the merger with Cancer Research Campaign to Cancer Research UK, London Research Institute) and Cardiff University. In 2007 he was awarded a New Investigator Grant Award from the Medical Research Council (UK) to establish himself as an independent Principle Investigator. In 2010 Dr. Donev was appointed Senior Lecturer at Swansea University. In 2016 Dr. Donev joined MicroPharm Ltd (UK) where currently he is Head of Research. He has published more than 60 research papers, chaired scientific meetings and given invited plenary talks. Rossen Donev has consulted on projects related to development of treatments for neurodevelopmental disorders and cancer therapies. He serves as Editor-in-Chief of the Advances in Protein Chemistry and Structural Biology and on editorial board of several other journals. His research interests include signaling pathways involved in neuropsychiatric disorders and tumor escape from the immune system, and development of therapeutic strategies for their treatment. More recently he has focused on development of immunotherapeutics for non-systemic applications.
Butikslager
Ej i lager i butik.
Betyg & recensioner
0 recensioner
Inga recensioner tillgängliga.